HSP90 N-terminal inhibitors target oncoprotein MORC2 for autophagic degradation and suppress MORC2-driven breast cancer progression.

Yang F, Sun R, Hou Z, Zhang FL, Xiao Y, Yang YS, Yang SY, Xie YF, Liu YY, Luo C, Liu GY, Shao ZM, Li DQ
Clin Transl Med. 2022 May;12(5):e825. doi: 10.1002/ctm2.825. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.